CD274 and neoplasm: Analyzing a cohort of 299 chemo-naïve patients who underwent treatment with a combination of platinum, pemetrexed, and pembrolizumab, the findings revealed a significant association between better performance status (0–1) and a higher PD-L1 tumor proportion score (≥50%) with improved PFS.